Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns
about
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesRisk Stratification in Differentiated Thyroid Cancer: An Ongoing ProcessMutation Profile of Well-Differentiated Thyroid Cancer in AsiansNomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerRAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.Molecular pathogenesis and mechanisms of thyroid cancerPreoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinomaInvasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.Molecular features of follicular variant papillary carcinoma of thyroid: comparison of areas with or without classical nuclear features.Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorderFresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.Association between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population.The follicular variant of papillary thyroid carcinoma: characteristics of preoperative ultrasonography and cytology.Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 casesMolecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testingPapillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.Ultrasonographic imaging of papillary thyroid carcinoma variants.The atypical thyroid fine-needle aspiration: past, present, and future.Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?Diagnosis and management of differentiated thyroid cancer using molecular biology.Diagnosis of thyroid cancer: state of art.Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective.Activated K-RAS and its effect on morphological appearance.Sonographic and cytopathologic correlation of papillary thyroid carcinoma variants.When thyroid carcinoma goes bad: a morphological and molecular analysis.Encapsulated Thyroid Carcinoma of Follicular Cell Origin.Molecular cytopathology for thyroid nodules: A review of methodology and test performance.Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
P2860
Q26751274-FA33ECC6-BB6F-4D27-A0D6-915D33153FB3Q26765083-95386CEB-7FA8-4169-A3A7-B6F5642F96E5Q26782322-6B1F1E1F-1C49-4C54-8742-424DBDD5B050Q28274899-33577EE4-74A4-41FF-A9A8-F52E989E4A97Q30367068-4684A738-3FAF-4E26-9E40-D28FB41AFB35Q33569996-9D361AE8-1F48-4D4B-BDC9-DF400D669573Q34295804-EE9A6578-8EB0-46D9-A05E-6BB9937D8229Q34329018-7A50A20C-E684-4EEF-A43B-C684AE638D89Q34461136-DF80ED60-2953-488C-8B00-907AF69A15A0Q34464782-DAEBF2F6-8168-44B4-9FF1-4D6FF31C710DQ34468149-417A4D88-567D-4EA1-BFCD-7C397215B9B5Q34716574-CC12F1B5-549C-4DE8-A9F6-B02CAA404D60Q34765342-47AF9C78-3D89-45D4-8E0F-A40768ED69E8Q35052882-806B2AB9-1E70-47BF-B494-BB7B313E8958Q35211953-36B2F61C-476B-4210-9E39-9016C5DF9F6DQ35691075-975211FD-65CC-46BA-B2AA-08C5E1D8F767Q36083709-25EF05B8-04E2-41CB-BF17-919AF9F14370Q36229033-B439B88D-E2D3-41D5-8AF2-C794CE317DF9Q36430456-FD5B5ECD-5D68-495F-BDB7-A6C839D98662Q36454877-2769D03C-42FD-4389-B369-0DB91AB3AB76Q36511670-9F642D65-A777-4E17-A04E-D066C73DB6A9Q37209097-B72C105E-92B0-4438-811C-FA2227CC3E43Q37293524-4BC0B9AD-25BA-4420-996C-7F2BECA521B7Q37550338-303C0028-88BF-43A0-B22E-3E6F22AE3E17Q37554783-B698DE57-2B2C-4955-B488-18869AFDA060Q37738818-2E1DB731-4C05-4219-981C-A544C80CEEDEQ37900569-7CFC7056-64C6-4EEA-B337-02456B8166D9Q37924711-C9B51094-915F-48BA-BAFB-71F2774D1041Q38081125-745B8BD9-9AC3-455E-B9AC-72A8B4BD96B9Q38108825-A24CC43B-4F06-4860-BF7E-33022323C756Q38162751-E79918A4-047E-4E8A-A4D7-8314A70D93FFQ38199071-78EE9E25-4EB2-4D92-A3FA-6CBCC0C5B3ACQ38222722-834397E2-903A-480F-BBE9-3817DEC68CD0Q38301479-2659C389-37D3-49D1-B583-DF4D34CA8F89Q38389256-5E51D830-C2F6-4767-8FEF-20B065FA5FDFQ38499954-6A11E9F3-6211-4451-8CE0-DDE68DCC1C18Q38582698-863F2ED9-AEAC-4683-96C8-55A5BA786087Q38677660-A5DEC1DD-3C8A-4FA6-9D78-AAABA6105B79Q38737374-8CE1E845-BCF6-4331-9233-69A18C8A66D6Q38785849-DEA76E2F-66A5-4AF7-91E2-353D3987ADF5
P2860
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@ast
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@en
Molecular genotyping of papill ...... g to its histological subtypes
@nl
type
label
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@ast
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@en
Molecular genotyping of papill ...... g to its histological subtypes
@nl
prefLabel
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@ast
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@en
Molecular genotyping of papill ...... g to its histological subtypes
@nl
P2093
P2860
P1433
P1476
Molecular genotyping of papill ...... BRAF and RAS mutation patterns
@en
P2093
Ashok Shaha
James A Fagin
Julio Ricarte-Filho
Michael Rivera
Michael Tuttle
Ronald A Ghossein
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.112
P577
2010-06-04T00:00:00Z
P5875
P6179
1020285106